« Back to Farmacia Journal 4/2022
RISK FACTORS, ORAL ANTICOAGULANTS-BASED THERAPEUTICAL APPROACHES AND COMORBIDITIES IN ATRIAL FIBRILLATION: 4216 PATIENTS FROM A ROMANIAN HOSPITAL
MIRELA MARIOARA TOMA 1, DELIA MIRELA TIT 1,2*, RADU DUMITRU MOLERIU 3, ALEXA
FLORINA BUNGAU 4, CAMELIA CRISTINA DIACONU 5,6, SIMONA GABRIELA BUNGAU 1,2
1Department of Biomedical Sciences, Doctoral School of the University of Oradea, University of Oradea, Oradea, 410087, Romania
2Pharmacy Department, Faculty of Medicine and Pharmacy, University of Oradea, Oradea, 410087, Romania
3Mathematics Department, Faculty of Mathematics and Computer Science, West University Timișoara, Timișoara, 30022, Romania
4Medicine Program of Study, Faculty of Medicine and Pharmacy, University of Oradea, Oradea, 410087, Romania
5Department of Internal Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, 050474, Romania 6Clinical Emergency Hospital of Bucharest, Bucharest, 105402, Romania